In addition, through DC‐SIGN, DNGR‐1 and DEC‐205 with appropriate adjuvants to target the delivery of tumour antigens can prevent the development of tumours or mediated eradication in transplanted mouse models.9, 35, 36, 37. Here, CLEC9A is linked to neoplasm.